Analysts
Firm Analyst
EF Hutton Jason Kolbert
Overcoming Hurdles in Immune Suppression and Drug ResistanceOpens in a new window
D. Boral Capital Jason Kolbert
Prostate Cancer Trial Expands Beyond CedarsOpens in a new window
Rodman and Renshaw Tony Butler
KAPA: The Critical Moment to Target Cancer Drug ResistanceOpens in a new window

Kairos Pharma, Ltd. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Kairos Pharma, Ltd.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kairos Pharma, Ltd. or its management. Kairos Pharma, Ltd. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.